Neurorehabilitation Unit, The NeMo Clinical Center in Milan, University of Milan, ASST Niguarda, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy.
Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital, London, UK.
Dysphagia. 2023 Dec;38(6):1568-1580. doi: 10.1007/s00455-023-10584-z. Epub 2023 Jun 8.
Bulbar and jaw muscles are impaired in patients with Spinal Muscular Atrophy (SMA) but the assessment of their severity and progression are limited by the lack of age-appropriate and disease-specific measures. We investigated mastication and swallowing in children and adults with SMA, sitters and walkers. In a 2-year multicentre cross-sectional prospective study, lip and tongue strength (Iowa Oral Performance Instrument), chewing and swallowing (Test of Masticating and Swallowing Solids), active mouth opening (aMMO) were compared to age-appropriate normative data. The perceived burden of oro-bulbar involvement (SMA-Health Index) was recorded. 78 patients were included, 45 children (median age 7.4 years),22 adults (median age 26.8 years) on nusinersen and 11 untreated (median age 32.7 years). Forty-three percent children had reduced mouth opening, 50% had prolonged total time to eat. These issues were more prominent in sitters than in walkers (p = 0.019, p = 0.014). Sixty-six percent needed increased swallows for bolus clearance. Nusinersen treated adults had median aMMO, tongue strength and total time at TOMASS values within normal range (z score: -1.40, -1.22, -1.32, respectively) whereas untreated adults had reduced aMMO (z score: -2.68) and tongue strength (z score: -2.20). Only a minority of children (2/17) and treated adults (5/21) reported burden in swallowing or mastication compared to all untreated adults (5/5). After 16 months, mastication and swallowing were stable in treated children and adults, whether sitters or walkers. The reported multimodal approach to assess oro-bulbar functions demonstrate that swallowing and mastication are impaired in SMA despite patients' perception. These results suggest a trend towards stabilization of oro-bulbar function in patients on long-term treatment with nusinersen.
延髓和颌面部肌肉在脊髓性肌萎缩症(SMA)患者中受损,但由于缺乏适合年龄的疾病特异性评估方法,其严重程度和进展的评估受到限制。我们研究了 SMA 患儿和成人、坐姿和行走者的咀嚼和吞咽功能。在一项为期 2 年的多中心横断面前瞻性研究中,我们比较了唇舌力量(爱荷华口腔功能测试)、咀嚼和吞咽(固体咀嚼吞咽测试)、张口主动度(aMMO)与年龄匹配的正常参考数据。同时记录了口腔-延髓受累的感知负担(SMA 健康指数)。共纳入 78 例患者,其中 45 例为儿童(中位年龄 7.4 岁),22 例为成人(中位年龄 26.8 岁),均接受 nusinersen 治疗,11 例未治疗(中位年龄 32.7 岁)。43%的患儿张口受限,50%患儿进食总时间延长。这些问题在坐姿者中比在行走者中更为突出(p = 0.019,p = 0.014)。66%的患儿需要增加吞咽次数以清除食团。接受 nusinersen 治疗的成年患者的 aMMO、舌力和 TOMASS 总时间的中位数均在正常范围内(z 评分:-1.40、-1.22、-1.32),而未治疗的成年患者的 aMMO 减少(z 评分:-2.68)和舌力(z 评分:-2.20)。与所有未治疗的成年患者(5/5)相比,只有少数儿童(2/17)和接受治疗的成年患者(5/21)报告吞咽或咀嚼有负担。在 16 个月后,无论坐姿或行走,接受治疗的儿童和成年患者的咀嚼和吞咽功能均保持稳定。该报告的多模式方法评估口腔-延髓功能表明,尽管患者有感知,但 SMA 仍存在吞咽和咀嚼功能受损。这些结果提示,nusinersen 长期治疗的患者口腔-延髓功能可能趋于稳定。